These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25563682)

  • 21. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
    Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
    Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent Ischemic Stroke: Strategies for Prevention.
    Oza R; Rundell K; Garcellano M
    Am Fam Physician; 2017 Oct; 96(7):436-440. PubMed ID: 29094912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual antiplatelet therapy after stroke or transient ischaemic attack - how long to treat? The duration of aspirin plus clopidogrel in stroke or transient ischaemic attack: a systematic review and meta-analysis.
    Ge F; Lin H; Liu Y; Li M; Guo R; Ruan Z; Chang T
    Eur J Neurol; 2016 Jun; 23(6):1051-7. PubMed ID: 27021849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.
    Sibbing D; Morath T; Braun S; Stegherr J; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2010 Jan; 103(1):151-9. PubMed ID: 20062919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clopidogrel Resistance Increases Rate of Recurrent Stroke and Other Vascular Events in Chinese Population.
    Yi X; Lin J; Zhou Q; Wu L; Cheng W; Wang C
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1222-1228. PubMed ID: 26935114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.
    Diener HC; Bogousslavsky J; Brass LM; Cimminiello C; Csiba L; Kaste M; Leys D; Matias-Guiu J; Rupprecht HJ;
    Lancet; 2004 Jul 24-30; 364(9431):331-7. PubMed ID: 15276392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is clopidogrel the antiplatelet drug of choice for high-risk patients with stroke/TIA?: Yes.
    Diener HC
    J Thromb Haemost; 2005 Jun; 3(6):1133-6. PubMed ID: 15946197
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of clopidogrel resistance in ischemic stroke patients.
    Fukuoka T; Furuya D; Takeda H; Dembo T; Nagoya H; Kato Y; Deguchi I; Maruyama H; Horiuchi Y; Tanahashi N
    Intern Med; 2011; 50(1):31-5. PubMed ID: 21212570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
    Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Switching from clopidogrel hydrogen sulfate to clopidogrel besylate. Impaired antiplatelet effect in patients with ischemic stroke].
    Meves SH; Overbeck U; Kaiser A; Krogias C; Neubauer H
    Nervenarzt; 2010 Aug; 81(8):992-7. PubMed ID: 20517690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful gestation and delivery using clopidogrel for secondary stroke prophylaxis: a case report and literature review.
    Reilly CR; Cuesta-Fernandez A; Kayaleh OR
    Arch Gynecol Obstet; 2014 Sep; 290(3):591-4. PubMed ID: 24798936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clopidogrel Resistance after Minor Ischemic Stroke or Transient Ischemic Attack is Associated with Radiological Cerebral Small-Vessel Disease.
    Lundström A; Wallén H; von Arbin M; Jörneskog G; Gigante B; Höeg Dembrower K; Laurencikas E; Laska AC
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2348-57. PubMed ID: 26303791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Meta-analysis on the efficacy and adverse events of aspirin plus clopidogrel versus aspirin-monotherapy in patients with ischemic stroke or transient ischemic attack].
    Yang C; Qian J; Tang X; Gao P; Hu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1430-5. PubMed ID: 26850406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].
    Morel O; Viellard C; Faure A; Jesel L; Ohlmann P; Desprez D; Chauvin M; Roul G; Grunebaum L; Bareiss P
    Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):21-9. PubMed ID: 17343035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project.
    Milionis H; Ntaios G; Papavasileiou V; Spengos K; Manios E; Elisaf M; Vemmos K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2769-2777. PubMed ID: 28756905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving perspectives on clopidogrel in the treatment of ischemic stroke.
    Gorelick P; Sechenova O; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):245-8. PubMed ID: 17220470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ticagrelor with clopidogrel on high on-treatment platelet reactivity in acute stroke or transient ischemic attack (PRINCE) trial: Rationale and design.
    Wang Y; Lin Y; Meng X; Chen W; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Liu L; Zhao X; Wang Y;
    Int J Stroke; 2017 Apr; 12(3):321-325. PubMed ID: 28381198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
    Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.